194 related articles for article (PubMed ID: 28380391)
1. A microhydrodynamic rationale for selection of bead size in preparation of drug nanosuspensions via wet stirred media milling.
Li M; Alvarez P; Bilgili E
Int J Pharm; 2017 May; 524(1-2):178-192. PubMed ID: 28380391
[TBL] [Abstract][Full Text] [Related]
2. Impact of process parameters on the breakage kinetics of poorly water-soluble drugs during wet stirred media milling: a microhydrodynamic view.
Afolabi A; Akinlabi O; Bilgili E
Eur J Pharm Sci; 2014 Jan; 51():75-86. PubMed ID: 24036164
[TBL] [Abstract][Full Text] [Related]
3. An Intensified Vibratory Milling Process for Enhancing the Breakage Kinetics during the Preparation of Drug Nanosuspensions.
Li M; Zhang L; Davé RN; Bilgili E
AAPS PharmSciTech; 2016 Apr; 17(2):389-99. PubMed ID: 26182907
[TBL] [Abstract][Full Text] [Related]
4. Impact of media material and process parameters on breakage kinetics-energy consumption during wet media milling of drugs.
Parker N; Rahman M; Bilgili E
Eur J Pharm Biopharm; 2020 Aug; 153():52-67. PubMed ID: 32522681
[TBL] [Abstract][Full Text] [Related]
5. Continuous production of drug nanoparticle suspensions via wet stirred media milling: a fresh look at the Rehbinder effect.
Monteiro A; Afolabi A; Bilgili E
Drug Dev Ind Pharm; 2013 Feb; 39(2):266-83. PubMed ID: 22503097
[TBL] [Abstract][Full Text] [Related]
6. Use of Bead Mixtures as a Novel Process Optimization Approach to Nanomilling of Drug Suspensions.
Guner G; Kannan M; Berrios M; Bilgili E
Pharm Res; 2021 Jul; 38(7):1279-1296. PubMed ID: 34169438
[TBL] [Abstract][Full Text] [Related]
7. Do Mixtures of Beads with Different Sizes Improve Wet Stirred Media Milling of Drug Suspensions?
Guner G; Mehaj M; Seetharaman N; Elashri S; Yao HF; Clancy DJ; Bilgili E
Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765182
[TBL] [Abstract][Full Text] [Related]
8. A combined microhydrodynamics-polymer adsorption analysis for elucidation of the roles of stabilizers in wet stirred media milling.
Bilgili E; Afolabi A
Int J Pharm; 2012 Dec; 439(1-2):193-206. PubMed ID: 23018114
[TBL] [Abstract][Full Text] [Related]
9. Kinetic and Microhydrodynamic Modeling of Fenofibrate Nanosuspension Production in a Wet Stirred Media Mill.
Guner G; Yilmaz D; Bilgili E
Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371746
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of fast dissolving pullulan films containing BCS class II drug nanoparticles for bioavailability enhancement.
Krull SM; Ma Z; Li M; Davé RN; Bilgili E
Drug Dev Ind Pharm; 2016; 42(7):1073-85. PubMed ID: 26567632
[TBL] [Abstract][Full Text] [Related]
11. Analysis of heat generation during the production of drug nanosuspensions in a wet stirred media mill.
Guner G; Seetharaman N; Elashri S; Mehaj M; Bilgili E
Int J Pharm; 2022 Aug; 624():122020. PubMed ID: 35842083
[TBL] [Abstract][Full Text] [Related]
12. Enhanced recovery and dissolution of griseofulvin nanoparticles from surfactant-free nanocomposite microparticles incorporating wet-milled swellable dispersants.
Bhakay A; Azad M; Vizzotti E; Dave RN; Bilgili E
Drug Dev Ind Pharm; 2014 Nov; 40(11):1509-22. PubMed ID: 23981202
[TBL] [Abstract][Full Text] [Related]
13. Elaborating the crystal transformation referenced microhydrodynamic model and fracture mechanism combined molecular modelling of irbesartan nanosuspensions formation in wet media milling.
Meng T; Li Y; Ma S; Zhang Q; Qiao F; Hou Y; Gao T; Yang J
Int J Pharm; 2023 Feb; 632():122562. PubMed ID: 36586631
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic Modeling of Wet Stirred Media Milling for Production of Drug Nanosuspensions.
Bilgili E; Guner G
AAPS PharmSciTech; 2020 Nov; 22(1):2. PubMed ID: 33222036
[TBL] [Abstract][Full Text] [Related]
15. Review of nanosuspension formulation and process analysis in wet media milling using microhydrodynamic model and emerging characterization methods.
Tian Y; Wang S; Yu Y; Sun W; Fan R; Shi J; Gu W; Wang Z; Zhang H; Zheng A
Int J Pharm; 2022 Jul; 623():121862. PubMed ID: 35671851
[TBL] [Abstract][Full Text] [Related]
16. An Enthalpy-Balance Model for Timewise Evolution of Temperature during Wet Stirred Media Milling of Drug Suspensions.
Guner G; Elashri S; Mehaj M; Seetharaman N; Yao HF; Clancy DJ; Bilgili E
Pharm Res; 2022 Sep; 39(9):2065-2082. PubMed ID: 35915319
[TBL] [Abstract][Full Text] [Related]
17. Redispersible fast dissolving nanocomposite microparticles of poorly water-soluble drugs.
Bhakay A; Azad M; Bilgili E; Dave R
Int J Pharm; 2014 Jan; 461(1-2):367-79. PubMed ID: 24333905
[TBL] [Abstract][Full Text] [Related]
18. Multi-faceted Characterization of Wet-milled Griseofulvin Nanosuspensions for Elucidation of Aggregation State and Stabilization Mechanisms.
Li M; Alvarez P; Orbe P; Bilgili E
AAPS PharmSciTech; 2018 May; 19(4):1789-1801. PubMed ID: 29603084
[TBL] [Abstract][Full Text] [Related]
19. Is the combination of cellulosic polymers and anionic surfactants a good strategy for ensuring physical stability of BCS Class II drug nanosuspensions?
Bilgili E; Li M; Afolabi A
Pharm Dev Technol; 2016; 21(4):499-510. PubMed ID: 25774989
[TBL] [Abstract][Full Text] [Related]
20. Hybrid nanocrystal-amorphous solid dispersions (HyNASDs) as alternative to ASDs for enhanced release of BCS Class II drugs.
Rahman M; Arevalo F; Coelho A; Bilgili E
Eur J Pharm Biopharm; 2019 Dec; 145():12-26. PubMed ID: 31622652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
